发明名称 |
USE OF FACTOR VIIA OR FACTOR VIIA EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN A SELECTED SUBPOPULATION OF ICH PATIENTS |
摘要 |
The invention relates to a method for preventing or attenuating one or more complications of intracerebral haemorrhage (ICH), the method comprising: (i) selecting an ICH patient who exhibits one or more of the following characteristics: age = 70, baseline ICH volume = 60 mL, baseline IVH volume = 5 mL, and elapsed time since onset of symptoms of less than about 2.5 hours; and (ii) administering to said patient in need thereof an effective amount of a first coagulation agent comprising Factor VIIa or a Factor VIIa equivalent. |
申请公布号 |
WO2009090240(A2) |
申请公布日期 |
2009.07.23 |
申请号 |
WO2009EP50488 |
申请日期 |
2009.01.16 |
申请人 |
NOVO NORDISK HEALTH CARE AG;SKOLNICK, BRETT;BRUN, NIKOLAI CONSTANTIN;BEGTRUP, KAMILLA |
发明人 |
SKOLNICK, BRETT;BRUN, NIKOLAI CONSTANTIN;BEGTRUP, KAMILLA |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|